Monitor whether Opaleye converts to a 13D (activist) filing or increases its stake. As a passive filer, no immediate control-related actions are expected.
GOSS drugs
GOSS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $10.65entry
- T+1 · 7d ago +5.97%α +6.33% · $11.28
- T+5 · 18h ago +3.15%α +4.84% · $10.98
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Opaleye Management Inc., Opaleye L.P., and James Silverman filed an amended Schedule 13G disclosing a 6.98% passive stake (426,989 shares) in Gossamer Bio as of September 30, 2026. This is an initial filing by this group; no prior 13G from Opaleye was found in the cross-filing context. The stake is held via the Fund (415,000 shares) and a separately managed account (11,989 shares).
Key Financial Metrics
Key Facts
- Opaleye Management Inc., Opaleye L.P., and James Silverman filed a Schedule 13G/A disclosing 6.98% beneficial ownership of Gossamer Bio common stock.
- Total shares beneficially owned: 426,989 as of September 30, 2026.
- Opaleye L.P. directly holds 415,000 shares; a separately managed account holds 11,989 shares.
- Issuer had 6,116,391 common shares outstanding as of September 14, 2026 (post-reverse stock split).
- This is an initial filing by this group; no prior 13G from Opaleye was found in the cross-filing context.
Financial Impact
6.98% passive stake valued at approximately $4.3M based on $61M market cap.
Risk Factors
- Opaleye could convert to a 13D and pursue activist strategies.
- A 6.98% stake gives Opaleye influence; any future selling could pressure the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001493152-26-050449 |
| Document: 0001493152-26-050449-index-headers.html | 0001493152-26-050449 |
| Document: 0001493152-26-050449-index.html | 0001493152-26-050449 |
| Document: 0001493152-26-050449.txt | 0001493152-26-050449 |
Track record
20 reports on GOSS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.28% at T+60 after the Jun 17, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today S-3 Neutral 3/10 Entry $10.98 Now $10.98 −0.00% settles Feb 16
- Nov 10, 20266d ago 8-K Neutral 5/10 Entry $11.69 Now $10.98 −6.07% settles Feb 9
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $10.65 Now $10.98 +3.15% settles Feb 5
- Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $9.77 Now $10.98 +12.38% settles Feb 4
- Oct 29, 202618d ago SC 13D/A Bearish 5/10 Entry $10.38 Now $10.98 −5.78% settles Jan 28
- Oct 8, 20265w ago SC 13D/A Bearish 5/10 Entry $9.31 Now $10.98 −17.94% settles Jan 6
- Sep 28, 20267w ago SC 13D/A Bearish 6/10 Entry $11.58 Now $10.98 +5.18% settles Dec 23
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $11.69 Now $10.98 −6.07% settles Dec 16
- Sep 16, 20268w ago 8-K Neutral 4/10 Entry $11.94 Now $10.98 −8.04% settles Dec 11
- Sep 11, 20269w ago 8-K Bearish 6/10 Entry $10.73 Now $10.98 −2.33% settles Dec 7
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers